36 Small Cap Stocks Hit 52-Week Highs On Friday
In a quiet market, a handful of small companies are hitting new highs, but not all strength is created equal.
As of Friday, 36 Small Cap stocks are trading at their 52-week highs. This is not a broad market surge; the S&P 500 has returned just +0.8% over the last month. The largest name on the list is Primerica (PRI), with a market value of about $10.0 billion.
The central question this list raises is simple: in a selective market, what kind of business is earning a new high? The names below show clusters in Biotechnology (3 names), Reinsurance (3 names), and Regional Banks (3 names).
The Ten Largest At New Highs
The table below shows the 10 largest of the 36 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| PRI | $10.0 Bil | 2.1% | 1.3% | 11.7% | 19.6% |
| HALO | $9.7 Bil | 1.3% | 5.3% | 15.2% | 39.9% |
| CUBE | $9.6 Bil | 2.6% | 0.5% | 5.1% | 7.2% |
| APGE | $9.4 Bil | 0.0% | 0.2% | 1.2% | 230.9% |
| AXS | $8.6 Bil | 1.6% | 1.5% | 10.3% | 21.7% |
| RHP | $8.4 Bil | 3.3% | 5.1% | 3.5% | 39.3% |
| HXL | $8.4 Bil | 0.4% | 6.2% | 15.5% | 77.8% |
| FAF | $7.7 Bil | 8.9% | 2.9% | 11.7% | 34.8% |
| PACS | $7.4 Bil | 4.5% | 1.6% | 20.6% | 292.1% |
| ACT | $6.6 Bil | 1.7% | 0.5% | 5.7% | 34.7% |
Has the business performance earned the new high?
Halozyme Therapeutics (HALO) stands out. The stock has gained 15.2% over the last month, but its business fundamentals show significant expansion. The company’s revenue grew 39.1% over the last twelve months, and it operates with a 56.1% operating margin.
Compare that to CubeSmart (CUBE), which trades at 29.3 times trailing earnings. Its revenue grew 5.0% over the last twelve months, with an operating margin of 39.5%. Both are at highs, but the underlying growth stories are very different.
Is a new high a reason to buy?
A 52-week-high list is a map of strength, and strong stocks often continue to perform. But a price is not a verdict on a company’s quality or future. It is simply a point of agreement in the market today.
The disciplined approach is to treat this list as a starting point for research. A new high is an alert that something is working. The real work is to look at the fundamentals, as we did above, and decide if the business itself justifies the price the market is paying for it.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.